Larry Michael Mertz - 13 Feb 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Technology Officer
Signature
/s/ Steven Reichling, attorney-in-fact
Issuer symbol
AXDX
Transactions as of
13 Feb 2023
Transactions value $
$0
Form type
4
Filing time
15 Feb 2023, 17:29:46 UTC
Previous filing
30 Aug 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Award $0 +116K $0.00 116K 13 Feb 2023 Common Stock 116K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The reporting person received restricted stock units on February 13, 2023, which will vest on March 2, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
F3 Not Applicable.